Advanced

A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission.

Chatzidionysiou, Katerina; Turesson, Carl LU ; Teleman, Annika; Knight, Ann; Lindqvist, Elisabet LU ; Larsson, Per; Cöster, Lars; Forslind, Kristina LU ; van Vollenhoven, Ronald and Heimbürger, Mikael (2016) In RMD open 2(1). p.000133-000133
Abstract
Treatment with tumour necrosis factor (TNF) blockers, once started as therapy for rheumatoid arthritis (RA), is usually continued indefinitely. The aim of this trial was to assess the possibility of discontinuing treatment with adalimumab (ADA) while maintaining remission in patients with RA with established disease in stable remission on combination therapy with ADA and methotrexate (MTX).
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
RMD open
volume
2
issue
1
pages
000133 - 000133
publisher
BMJ Publishing Group
external identifiers
  • PMID:26819752
  • Scopus:84988447917
ISSN
2056-5933
DOI
10.1136/rmdopen-2015-000133
language
English
LU publication?
yes
id
b2878c4b-49eb-45b5-9d29-dcce21d61a17 (old id 8573144)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/26819752?dopt=Abstract
date added to LUP
2016-02-06 12:46:40
date last changed
2017-01-22 04:20:18
@article{b2878c4b-49eb-45b5-9d29-dcce21d61a17,
  abstract     = {Treatment with tumour necrosis factor (TNF) blockers, once started as therapy for rheumatoid arthritis (RA), is usually continued indefinitely. The aim of this trial was to assess the possibility of discontinuing treatment with adalimumab (ADA) while maintaining remission in patients with RA with established disease in stable remission on combination therapy with ADA and methotrexate (MTX).},
  author       = {Chatzidionysiou, Katerina and Turesson, Carl and Teleman, Annika and Knight, Ann and Lindqvist, Elisabet and Larsson, Per and Cöster, Lars and Forslind, Kristina and van Vollenhoven, Ronald and Heimbürger, Mikael},
  issn         = {2056-5933},
  language     = {eng},
  number       = {1},
  pages        = {000133--000133},
  publisher    = {BMJ Publishing Group},
  series       = {RMD open},
  title        = {A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission.},
  url          = {http://dx.doi.org/10.1136/rmdopen-2015-000133},
  volume       = {2},
  year         = {2016},
}